Retrospektivna analiza doze zračenja s obzirom na iskustvo operatera tijekom perkutanih koronarnih intervencija u akutnom infarktu miokarda sa ST-elevacijom
DOI:
https://doi.org/10.55378/rv.50.2.1Ključne riječi:
STEMI, primarna perkutana koronarna intervencija, kumulativna zračna kerma, fluoroskopija, kontrastno sredstvo, iskustvo operatera, radiološka zaštitaSažetak
Sažetak
Uvod: Primarna perkutana koronarna intervencija (pPCI) standardni je oblik reperfuzijskog liječenja bolesnika sa STEMI-jem. Postupak uključuje izlaganje ionizirajućem zračenju i primjenu kontrastnog sredstva, a na njihovu razinu mogu utjecati karakteristike bolesnika, složenost zahvata i iskustvo operatera. Cilj istraživanja bio je analizirati povezanost iskustva operatera s dozom zračenja, fluoroskopskim vremenom i količinom kontrastnog sredstva, uz poseban naglasak na kumulativnu zračnu kermu (CAK).
Ispitanici i metode: Provedena je retrospektivna analiza 1140 bolesnika sa STEMI-jem liječenih pPCI metodom od 1. siječnja 2021. do 31. prosinca 2025. Bolesnici su prema vrijednosti troponina pri prijemu podijeljeni na skupinu s urednim troponinom (n = 293) i skupinu s povišenim troponinom (n = 847). U zahvatima je sudjelovalo 10 interventnih kardiologa, podijeljenih na seniore, srednje iskusne operatere i juniore. Analizirani su CAK, fluoroskopsko vrijeme, količina kontrasta, dob i spol. Razlike su procijenjene ANOVA-om i Duncanovim post-hoc testom, a neovisni prediktori multivarijatnom linearnom regresijom.
Rezultati: U skupini s urednim troponinom nisu utvrđene značajne razlike između skupina operatera. U skupini s povišenim troponinom iskustvo operatera bilo je značajno povezano s CAK-om (F = 11,6; p < 0,001), fluoroskopskim vremenom (F = 4,2; p = 0,0151) i količinom kontrasta (F = 13,9; p < 0,001). Najviši CAK zabilježen je kod juniora (2254,2 mGy), a najniži kod srednje iskusnih operatera (1561,5 mGy). Nakon prilagodbe, dob i spol bili su neovisni prediktori većeg CAK-a, dok je iskustvo operatera bilo povezano s manjom potrošnjom kontrasta. Model CAK-a objasnio je približno 3 % varijabilnosti.
Zaključak: Utjecaj iskustva operatera najizraženiji je u bolesnika s povišenim troponinom. CAK je nakon prilagodbe prvenstveno povezan s karakteristikama bolesnika, dok je potrošnja kontrasta osjetljivija na iskustvo operatera. Optimizacija pPCI-ja treba uključivati načelo ALARA, individualizaciju postupka, racionalnu primjenu kontrasta te kontinuiranu edukaciju i superviziju manje iskusnih operatera.
Reference
Collet JP, Thiele H, Barbato E, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826.
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–177.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618–e651.
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation. 2013;127(4):e362–e425.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20.
Valgimigli M, Bueno H, Byrne RA, et al. 2018 ESC Guidelines for the management of myocardial revascularization. Eur Heart J. 2018;39(2):87–165.
Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With STEMI. Circulation. 2016;133(11):1135–1147.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20.
Lo TS, Ratib K, Chong A-Y, Bhatia G, Gunning M, Nolan J. Impact of access site selection and operator expertise on radiation exposure: a controlled prospective study. Am Heart J. 2012 Oct;164(4):455–461. doi:10.1016/j.ahj.2012.06.011.
Simard T, Hibbert B, Natarajan MK, Mercuri M, Hetherington SL, Wright R, et al. Impact of center experience on patient radiation exposure during transradial coronary angiography and percutaneous intervention: a patient-level, international, collaborative, multi-center analysis. J Am Heart Assoc. 2016;5:e003333. doi:10.1161/JAHA.116.003333.
Kaul P, Medvedev S, Hohmann SF, Douglas PS, Peterson ED, Patel MR. Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States. Circulation. 2010 Nov 23;122(21):2160–2169. doi:10.1161/CIRCULATIONAHA.110.973339.
Faj D, Baraban V, Brnić Z, Boban D, Steiner R, Kasabašić M, Kubelka D. Doze zračenja koje bolesnik apsorbira tijekom koronarnih intervencija u KBC-u Osijek [Patient radiation doses received during interventional cardiology procedures at the University Hospital Osijek]. Arh Hig Rada Toksikol. 2010;61 Suppl:131-137.
Abreu LM. Time is muscle. Arq Bras Cardiol. 2019;112(4):408-409. doi:10.5935/abc.20190059.
International Atomic Energy Agency (IAEA). Radiation doses in interventional fluoroscopy [Internet]. Vienna: IAEA; [cited 2026 Mar 12]. Available from: https://www.iaea.org/resources/rpop/health-professionals/interventional-procedures/radiation-doses-in-interventional-fluoroscopy
European Society of Cardiology. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826. doi:10.1093/eurheartj/ehad191.
Nicola S. Vos, Nick D. Fagel, Giovanni Amoroso, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial. JACC Cardiovasc Interv. 2019;12(17):1691–1699. doi:10.1016/j.jcin.2019.04.016.
Stocker TJ, Möllmann H, Abdel-Wahab M, et al. Trends and predictors of radiation exposure in percutaneous coronary intervention. EuroIntervention. 2022;18(3):e256–e264. doi:10.4244/EIJ-D-21-00856.
Januszek R, et al. Predictors and trends of contrast use and radiation exposure in patients treated with percutaneous coronary intervention within chronic total occlusion lesions. Cardiol J. 2023;30(6):892–903.
Balter S, Moses J, Hyasat K, et al. Evolving operator practices reduced patient radiation dose in interventional cardiology: trends in a single center. Am Heart J. 2025.
Kansal V, Simard T, Di Santo P, et al. Impact of trainee involvement on patient radiation exposure and contrast volumes during invasive cardiac procedures. Clin Invest Med. 2020;43(1):E18-E21.
Laušić H. Retrospektivna analiza doze zračenja s obzirom na iskustvo operatera tijekom perkutanih koronarnih intervencija u akutnom infarktu miokarda sa ST-elevacijom (Master‘thesis), Split: Faculty of Health Sciences, University of Split; 2026. (accessed 6 September 2026). Available at: https://repo.ozs.unist.hr/object/ozs:2184/FILE0
Preuzimanja
Objavljeno
Broj časopisa
Rubrika
Kategorije
Licenca
Autorska prava (c) 2026 Hrvoje Lausic (Author); Doc. dr. sc. Kristina Maric Besic, izv. prof. dr. sc. Tonci Batinic

This work is licensed under a KreativniCommons Attribution-NonCommercial Međunarodne licence.
HDRT